GW823296 Repeat Dose Study In Healthy Male And Female Subjects
NCT00675116 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2010-10-15
Summary
This is a study to evaluate the safety, tolerability and pharmacokinetics of GW823296 following 28 days, once-daily repeat oral doses.
Conditions
- Healthy Subjects
Interventions
- DRUG
-
GW823296
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials, MD · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-04-30
- Primary Completion
- 2008-07-31
- Completion
- 2008-07-31
Countries
- Australia
Study Locations
More Related Trials
-
A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
NCT04612517 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers
NCT00754715 ·Status: COMPLETED ·Phase: PHASE1
-
GSK706769 A First Time in Human Study For Males and Females
NCT00539201 ·Status: TERMINATED ·Phase: PHASE1
-
Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects
NCT06063291 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacodynamic and Pharmacokinetic Effects of QAX576 in Healthy Volunteers.
NCT00417196 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects
NCT06635226 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830
NCT02751424 ·Status: TERMINATED ·Phase: PHASE1
-
A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Genz-682452 in Healthy Volunteers
NCT01710826 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects
NCT02742766 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety, Tolerability and Pharmacokinetics of Oral NNZ-2591 in Healthy Volunteers
NCT04379869 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of AZD7295 Capsules
NCT01097408 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety, Tolerability and Pharmacokinetics of HY6725 in Healthy Adult Participants
NCT07262281 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Ascending Doses of AZD5069 in Healthy Volunteers
NCT01051505 ·Status: COMPLETED ·Phase: PHASE1
-
Single Ascending Dose Study of TD-0714 in Healthy Subjects
NCT02639078 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial of GX-I7 in Healthy Volunteers
NCT02860715 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Study Single- and Multiple- Doses of GSM-779690T in Healthy Participants
NCT07155980 ·Status: WITHDRAWN ·Phase: PHASE1
-
AZD6765 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese and Caucasian Subjects
NCT00785915 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Safety, Tolerability, and Pharmacokinetics of GDC-0310 in Healthy Volunteers
NCT02742779 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8529 Single Ascending Dose Study
NCT00755378 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy Volunteers
NCT03742791 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male Volunteers
NCT02183545 ·Status: COMPLETED ·Phase: PHASE1
-
A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy Volunteers
NCT06103877 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy Subjects
NCT00796965 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of TAK-828 Escalating Multiple-Doses in Healthy Participants
NCT02817516 ·Status: TERMINATED ·Phase: PHASE1
-
A Study Designed to Evaluate the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Mimetic GC4711 in Healthy Volunteers
NCT03762031 ·Status: COMPLETED ·Phase: PHASE1